Entries by PR Newswire


Kintara Therapeutics Granted Fast Track Designation from FDA for REM-001 for Cutaneous Metastatic Breast Cancer

Kintara Therapeutics Inc., a biopharmaceutical company focused on the development of new solid tumor cancer therapies, announced that the United States Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to Kintara’s REM-001 Therapy for the treatment of patients with cutaneous metastatic breast cancer (CMBC).

, ,

Havas Health & You appoints Paul Pfleiderer as president of Havas Life New York

As the rapid evolution of the health and wellness sector continues to necessitate innovative thinking and activation across the industry, Havas Health & You appointed seasoned strategic leader Paul Pfleiderer as President of Havas Life New York. Pfleiderer will work closely with Havas Life Group President Denise Henry to drive the agency’s growth and strengthen its market leadership presence through exceptional client work and culture.